Profile data is unavailable for this security.
About the company
Jack Chia Industries (Thailand) Public Company Limited is a personal care and medical supplies provider. The Company is engaged in the manufacture and distribution of pharmaceutical products and cosmetics. It operates through two segments: manufacture and distribution of pharmaceutical products and manufacture and distribution of other consumer products. The Company’s products include Tigerplast, Tensoplast, Kangaroo, Tabu, Thermaplast, Jason, Ronson and Golden Lion. The Company’s product offerings under the Tigerplast brand include Tigerplast Extra Comfort Knee Support, Tigerplast Extra Comfort Ankle Support, Tigerplast Extra Comfort Wrist Support, Tigerplast Elastic Fabric Adhesive Dressing and others. The Company offers various products under the Tabu brand, such as Tabu Shower Cream, Tabu Soap, Tabu Perfumed Talcum, Klear After Shave By Tabu and Klear Ice Cologne By Tabu. The Company’s subsidiaries include Pharmacare Limited and JCT New Frontiers Holdings Limited.
- Revenue in THB (TTM)872.89m
- Net income in THB123.68m
- Incorporated1966
- Employees307.00
- LocationJack Chia Industries Thailand PCL114/1 Soi Chalongkrung 31Lumplatew, Ladkrabang,BANGKOK 10520ThailandTHA
- Phone+66 22360036
- Fax+66 22361379
- Websitehttps://www.jackchia.co.th/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nutrition Profess PCL | 1.08bn | 66.15m | 487.20m | -- | 7.37 | 0.9954 | 4.42 | 0.4502 | 0.5512 | 0.5512 | 9.02 | 4.08 | -- | -- | -- | -- | -- | -- | -- | -- | 85.40 | -- | 6.11 | -- | 3.71 | 14.40 | 0.1617 | -- | -1.84 | -- | -15.21 | -- | -- | -- |
| JSP Pharmactcl Mnfctrng (Thailand) PCL | 993.15m | 10.04m | 934.91m | 451.00 | 93.10 | 1.05 | 25.23 | 0.9414 | 0.0212 | 0.0212 | 2.09 | 1.88 | 0.7122 | 4.89 | 8.00 | 2,202,116.00 | -2.30 | 0.7228 | -2.89 | 0.873 | 40.68 | 31.82 | -3.24 | 1.39 | 1.14 | 6.35 | 0.2271 | -- | 43.24 | 17.98 | 363.18 | -28.11 | 22.27 | -- |
| Jack Chia Industries Thailand PCL | 872.89m | 123.68m | 1.12bn | 307.00 | 9.06 | 0.7882 | 8.04 | 1.28 | 9.16 | 9.16 | 64.66 | 105.30 | 0.5505 | 1.83 | 3.95 | 2,843,285.00 | 7.80 | 5.54 | 8.28 | 6.01 | 45.35 | 42.40 | 14.17 | 10.51 | 8.03 | 53.88 | 0.00 | 64.24 | -6.82 | -1.39 | 3.72 | 1.70 | -3.13 | 1.39 |
| Specialty Natural Products PCL | 522.45m | 102.86m | 1.90bn | 285.00 | 18.43 | 2.20 | 14.85 | 3.63 | 0.2540 | 0.2540 | 1.29 | 2.13 | 0.6293 | 2.50 | 4.23 | 1,833,145.00 | 12.17 | 12.42 | 15.35 | 15.64 | 40.62 | 38.86 | 19.34 | 17.55 | 7.62 | 261.91 | 0.0036 | -- | 28.20 | 31.58 | 120.19 | 49.42 | -- | -- |
| Bangkok Lab and Cosmetic PCL | 1.68bn | 188.48m | 2.51bn | 1.11k | 13.31 | 1.49 | 9.97 | 1.49 | 0.3141 | 0.3141 | 2.80 | 2.81 | 0.732 | 2.74 | 4.66 | 1,517,711.00 | 8.36 | 7.24 | 10.41 | 12.57 | 30.39 | 28.80 | 11.42 | 8.08 | 1.44 | 31.98 | 0.1135 | -- | 10.73 | 5.31 | 17.85 | 142.44 | 16.91 | -- |
| Inter Pharma PCL | 2.15bn | 112.01m | 2.66bn | 162.00 | 23.78 | 1.31 | 11.10 | 1.24 | 0.185 | 0.185 | 3.56 | 3.36 | 0.6962 | 3.64 | 6.89 | 13,293,500.00 | 4.00 | 3.98 | 5.34 | 5.19 | 40.52 | 40.40 | 5.75 | 6.01 | 1.23 | 7.92 | 0.1549 | 23.26 | 6.52 | 38.23 | -26.60 | -3.03 | 160.41 | -- |
| T Man Pharmaceutical PCL | 2.35bn | 449.38m | 4.76bn | 960.00 | 10.59 | 2.46 | 8.36 | 2.02 | 1.12 | 1.12 | 5.88 | 4.84 | 0.754 | 2.03 | 3.64 | 2,452,049.00 | 14.40 | -- | 33.57 | -- | 47.67 | -- | 19.09 | -- | 0.9128 | 17.38 | 0.3316 | -- | 12.19 | -- | 4.55 | -- | -- | -- |
